News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tardio Jason
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.5, valued at
$437.5k
|
|
| 09/14/2022 |
4
| Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Sold 17,344 shares
@ $2.15, valued at
$37.3k
|
|
| 04/12/2022 |
4
| Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 87,498 options to buy
@ $3.22, valued at
$281.7k
Granted 10,000 options to buy
@ $3.22, valued at
$32.2k
|
|
| 02/04/2022 |
4
| Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.72, valued at
$476k
|
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Tardio Jason (Chief Commercial Officer) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 75,000 options to buy
@ $7.4, valued at
$555k
|
|
| 12/21/2020 |
4
| Tardio Jason (Chief Commercial Officer) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.82, valued at
$493.5k
|
|
| 06/23/2020 |
4
| Tardio Jason (Chief Commercial Officer) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 50,000 options to buy
@ $7.4, valued at
$370k
|
|
| 11/21/2019 |
4
| Tardio Jason (Chief Commercial Officer) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 125,000 options to buy
@ $2.76, valued at
$345k
|
|
| 11/21/2019 |
3
| Tardio Jason (Chief Commercial Officer) has filed a Form 3 on Ovid Therapeutics Inc. |
|
|